| Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders (NCT05108558) | Charitable Union for the Research and Education of Peyronie's Disease | 2021-09-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis (NCT05147779) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-09-12 |
| Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's (NCT04786106) | Charitable Union for the Research and Education of Peyronie's Disease | 2020-12-30 |
| Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response (NCT03767452) | Manhattan Medical Research Practice, PLLC | 2018-10-04 |
| Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease (NCT02298829) | Endo USA Inc., a Keenova Therapeutics Company | 2014-11-01 |
| An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's Disease (NCT02267460) | Endo USA Inc., a Keenova Therapeutics Company | 2014-10-01 |
| Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PD (NCT02395029) | Melissa Marchand | 2013-08-01 |
| Peyronie's Disease Treatment Protocol (NCT02072018) | Hybrid Medical | 2013-06-01 |
| Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease (NCT01578473) | Men's Health Boston | 2013-05-23 |
| A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease (NCT01685437) | Endo USA Inc., a Keenova Therapeutics Company | 2012-09-01 |
| A Study of AA4500 in Men With Peyronie's Disease (NCT01243411) | Endo USA Inc., a Keenova Therapeutics Company | 2010-11-01 |
| Study of AA4500 in the Treatment of Peyronie's Disease (NCT01221597) | Endo USA Inc., a Keenova Therapeutics Company | 2010-09-01 |
| H-22411: BOTOX® for Peyronie's Disease (NCT00812838) | Mohit Khera | 2009-08-07 |
| The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease (NCT00755222) | Endo USA Inc., a Keenova Therapeutics Company | 2008-08-01 |